Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

BioStock: Stayble Therapeutics shifts focus to phase Ib study in disc herniation

Stayble Therapeutics

Following dissapointing results from the phase IIb study, Stayble Therapeutics is shifting its focus to the phase Ib study in hearniated disc patients. At the same time, the company plans to reduce costs in order to complete the study without additional funding. CEO Andreas Gerward shares more details in an interview with BioStock. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/stayble-therapeutics-shifts-focus-to-phase-ib-study-in-disc-herniation/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.